IFP Advisors’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.5K | Buy |
1,282
+1,147
| +850% | +$29.6K | ﹤0.01% | 2520 |
|
|
2026
Q1 | $2.48K | Buy |
135
+110
| +440% | +$2.09K | ﹤0.01% | 3874 |
|
|
2025
Q4 | $394 | Sell |
25
-7
| -22% | -$125 | ﹤0.01% | 4340 |
|
|
2025
Q3 | $620 | Sell |
32
-67
| -68% | -$1.31K | ﹤0.01% | 4114 |
|
|
2025
Q2 | $2.05K | Buy |
99
+26
| +36% | +$541 | ﹤0.01% | 3890 |
|
|
2025
Q1 | $1.79K | Buy |
73
+39
| +115% | +$1K | ﹤0.01% | 3177 |
|
|
2024
Q4 | $813 | Buy |
34
+26
| +325% | +$826 | ﹤0.01% | 3321 |
|
|
2024
Q3 | $339 | Sell |
8
-20
| -71% | -$1.05K | ﹤0.01% | 3174 |
|
|
2024
Q2 | $1.44K | Buy |
28
+20
| +250% | +$1.13K | ﹤0.01% | 2901 |
|
|
2024
Q1 | $500 | Sell |
8
-88
| -92% | -$5.99K | ﹤0.01% | 2975 |
|
|
2023
Q4 | $7.19K | Buy |
96
+13
| +16% | +$930 | ﹤0.01% | 2300 |
|
|
2023
Q3 | $7.07K | Buy |
83
+50
| +152% | +$4.74K | ﹤0.01% | 2397 |
|
|
2023
Q2 | $3.6K | Sell |
33
-5
| -13% | -$474 | ﹤0.01% | 2657 |
|
|
2023
Q1 | $2.16K | Sell |
38
-1,469
| -97% | -$138K | ﹤0.01% | 2871 |
|
|
2022
Q4 | $123K | Sell |
1,507
-43
| -3% | -$4.95K | ﹤0.01% | 1632 |
|
|
2022
Q3 | $126K | Buy |
1,550
+40
| +3% | +$4.38K | ﹤0.01% | 1698 |
|
|
2022
Q2 | $120K | Hold |
1,510
| – | – | ﹤0.01% | 1572 |
|
|
2022
Q1 | $120K | Buy |
1,510
+1,198
| +384% | +$124K | ﹤0.01% | 1572 |
|
|
2021
Q4 | $40K | Sell |
312
-42
| -12% | -$4.66K | ﹤0.01% | 1637 |
|
|
2021
Q3 | $42K | Sell |
354
-29
| -8% | -$3.08K | ﹤0.01% | 1653 |
|
|
2021
Q2 | $37K | Buy |
383
+207
| +118% | +$18K | ﹤0.01% | 1649 |
|
|
2021
Q1 | $13K | Sell |
176
-55
| -24% | -$4.09K | ﹤0.01% | 2018 |
|
|
2020
Q4 | $15K | Sell |
231
-33
| -13% | -$2.15K | ﹤0.01% | 1889 |
|
|
2020
Q3 | $15K | Hold |
264
| – | – | ﹤0.01% | 1747 |
|
|
2020
Q2 | $11K | Sell |
264
-5,166
| -95% | -$247K | ﹤0.01% | 1774 |
|
|
2020
Q1 | $291K | Buy |
5,430
+5,074
| +1,425% | +$347K | 0.03% | 464 |
|
|
2019
Q4 | $22K | Sell |
356
-28
| -7% | -$1.66K | ﹤0.01% | 1577 |
|
|
2019
Q3 | $22K | Buy |
+384
| New | +$21.3K | ﹤0.01% | 1717 |
|
|
2019
Q1 | – | Sell |
-594
| Closed | -$34K | – | 2387 |
|
|
2018
Q4 | $34K | Sell |
594
-55
| -8% | -$3.08K | ﹤0.01% | 1823 |
|
|
2018
Q3 | $36K | Sell |
649
-4
| -0.6% | -$229 | ﹤0.01% | 2075 |
|
|
2018
Q2 | $38K | Buy |
653
+125
| +24% | +$7.46K | ﹤0.01% | 2079 |
|
|
2018
Q1 | $26K | Hold |
528
| – | – | ﹤0.01% | 2212 |
|
|
2017
Q4 | $26K | Buy |
528
+126
| +31% | +$5.74K | ﹤0.01% | 2241 |
|
|
2017
Q3 | $18K | Buy |
402
+114
| +40% | +$4.36K | ﹤0.01% | 2654 |
|
|
2017
Q2 | $11K | Sell |
288
-9
| -3% | -$345 | ﹤0.01% | 2935 |
|
|
2017
Q1 | $12K | Hold |
297
| – | – | ﹤0.01% | 2798 |
|
|
2016
Q4 | $11K | Sell |
297
-8
| -3% | -$273 | ﹤0.01% | 2834 |
|
|
2016
Q3 | $10K | Buy |
305
+76
| +33% | +$2.89K | ﹤0.01% | 2817 |
|
|
2016
Q2 | $9K | Buy |
+229
| New | +$8.47K | ﹤0.01% | 2782 |
|
|
2016
Q1 | – | Sell |
-770
| Closed | -$24K | – | 2387 |
|
|
2015
Q4 | $24K | Buy |
+770
| New | +$22.8K | ﹤0.01% | 2051 |
|
Other funds holding AMN
IFP Advisors's AMN Position: Q2 2026 in Review
IFP Advisors increased its AMN Healthcare (AMN) stake by 850% in Q2 2026, buying an estimated $29.6K and bringing the position to 1,282 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2520.
IFP Advisors first reported a position in AMN in Q4 2015 and has held it in 40 quarters since. The position peaked at $291K in Q1 2020. 284 funds tracked by Wall St. Rank hold AMN as of Q2 2026.
- IFP Advisors held 1,282 shares of AMN Healthcare worth $41.5K as of Q2 2026.
- IFP Advisors bought 1,147 AMN Healthcare shares in Q2 2026, an estimated $29.6K.
- AMN Healthcare made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2520 holding.
- IFP Advisors first reported a position in AMN Healthcare in Q4 2015 and has held it in 40 quarters since.
- IFP Advisors's AMN Healthcare position peaked at $291K in Q1 2020.
- 284 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.